Article Information
PubMed
Published By
History
- Received March 2, 2013
- Revision received August 6, 2013
- Accepted August 12, 2013
- First published September 11, 2013.
- Version of record published September 11, 2013.
Copyright & Usage
Copyright © 2013 the authors 0270-6474/13/3314869-09$15.00/0
Author Information
Author contributions
Author contributions: S.A., P.R.H., and P.J.G. designed research; S.A., P.R.H., and M.P.L. performed research; S.A. analyzed data; S.A., P.R.H., and P.J.G. wrote the paper.
↵*S.A. and P.R.H. contributed equally to this work.
Disclosures
- Received March 2, 2013.
- Revision received August 6, 2013.
- Accepted August 12, 2013.
This work was supported by the Wellcome Trust and Sandler Family Foundation. We thank Thorsten Bartsch and the Headache Group of the University of California, San Francisco, for their assistance and technical support during these experiments.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Simon Akerman, Department of Neurology, University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158. akermans{at}neurology.ucsf.edu
Statistics from Altmetric.com
Article usage
In this issue
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine
